| Literature DB >> 33389967 |
Maximilian Lenz1, Kaliye Mohamud1, Jan Bredow1, Stavros Oikonomidis1, Peer Eysel1, Max Joseph Scheyerer1.
Abstract
We aimed to systematically review the literature to analyze the differences in posterior lumbar interbody fusion (PLIF), anterior lumbar interbody fusion (ALIF), and transforaminal lumbar interbody fusion (TLIF), focusing on the complications, risk factors, and fusion rate of each approach. Spinal fusion surgery is a well-established surgical procedure for a variety of indications, and different approaches developed. The various approaches and their advantages, as well as approach-related pathology and complications, are well investigated in spinal surgery. Focusing only on lumbosacral fusion, the comparative studies of different approaches remain fewer in numbers. We systematically reviewed the literature on the complications associated with lumbosacral interbody fusion. Only the PLIF, ALIF, or TLIF approaches and studies published within the last decade (2007-2017) were included. The exclusion criteria in this study were oblique lumbar interbody fusion, extreme lateral interbody fusion, more than one procedure per patient, and reported patient numbers less than 10. The outcome variables were indications, fusion rates, operation time, perioperative complications, and clinical outcome by means of Visual Analog Scale, Oswestry Disability Index, and Japanese Orthopaedic Association score. Five prospective, 17 retrospective, and two comparative studies that investigated the lumbosacral region were included. Mean fusion rates were 91,4%. ALIF showed a higher operation time, while PLIF resulted in greater blood loss. In all approaches, significant improvements in the clinical outcome were achieved, with ALIF showing slightly better results. Regarding complications, the ALIF technique showed the highest complication rates. Lumbosacral fusion surgery is a treatment to provide good results either through an approach for various indications as causes of lower back pain. For each surgical approach, advantages can be depicted. However, perioperative complications and risk factors are numerous and vary with ALIF, PLIF, and TLIF procedures, as well as with fusion rates.Entities:
Keywords: Anterior lumbar interbody fusion; Complications; L5/S1 fusion; Posterior lumbar interbody fusion; Risk factors; Transforaminal lumbar interbody fusion
Year: 2021 PMID: 33389967 PMCID: PMC8873994 DOI: 10.31616/asj.2020.0405
Source DB: PubMed Journal: Asian Spine J ISSN: 1976-1902
Fig. 1Outline of the literature research according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
Follow-up data in months regarding minimum follow-up, mean follow-up, and range in months of follow-up
| Author | Min follow-up (mo) | Mean follow-up (mo) | Range (mo) |
|---|---|---|---|
| Hsieh et al. [ | 12 | 22.36 | 12–37 |
| Mobbs et al. [ | 10 | 15 | NA |
| Lee et al. [ | 12 | NA | NA |
| Pinson et al. [ | 36 | NA | NA |
| De Kunder et al. [ | 2 | NA | 2–12 |
| Hayashi et al. [ | 24 | 40.45 | 24–74 |
| Rothenfluh et al. [ | NA | NA | NA |
| Kim et al. [ | 24 | NA | NA |
| Okuda et al. [ | 24 | 96 | 24–204 |
| Gologorsky et al. [ | 37 | 52 | 37–63 |
| Sakaura et al. [ | 24 | 35.4 | 25–41 |
| Dorward et al. [ | 24 | 33 (TLIF), 52 (ALIF) | NA |
| Makino et al. [ | 24 | 24 | NA |
| Fleege et al. [ | NA | 94.8 (ALIF), 67.2 (PLIF) | NA |
| Baeesa et al. [ | NA | 219 | 243–267 |
| Lara-Almunia et al. [ | 12 | NA | NA |
| Malham et al. [ | NA | 34.1 | 24–60 |
| Audat et al. [ | 3 | NA | 3–36 |
| Hosono et al. [ | 12 | 75.8 | 12–110 |
| Min et al. [ | 24 | 44.6 | 24–68 |
| Quraishi et al. [ | NA | NA | NA |
| Rao et al. [ | NA | 20 | 12–42 |
| Li et al. [ | NA | 4.3 | 2–7 |
| Jang et al. [ | 3 | NA | NA |
| Mean of all | 19 | 53.9 | 2–267 |
NA, not available; TLIF, transforaminal lumbar interbody fusion; ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion.
Overview of indications with ALIF, PLIF, and TLIF approach
| Indication for surgery | ALIF | PLIF | TLIF | |||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| No. of studies | No. of patients | No. of studies | No. of patients | No. of studies | No. of patients | |
| Degenerative disc disease | 3 | 465 | 2 | 72 | 1 | 37 |
|
| ||||||
| Degenerative spondylolisthesis | 3 | 40 | 5 | 173 | 3 | 202 |
|
| ||||||
| Isthmic spondylolisthesis | 4 | 114 | 6 | 240 | 1 | 15 |
|
| ||||||
| General spondylolisthesis | 3 | 76 | 2 | 289 | ||
|
| ||||||
| Scoliosis | 3 | 42 | 1 | 31 | ||
|
| ||||||
| Spinal stenosis | 2 | 35 | 1 | 398 | ||
|
| ||||||
| Disc herniation | 1 | 54 | ||||
ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.
Fusion rates
| Fusion method | No. of studies | Fusion rate (%) |
|---|---|---|
| ALIF | 6 | 97.8±2.61 (94.4–100.0) |
| PLIF | 9 | 91.4±4.51 (84.0–100.0) |
| TLIF | 2 | 96.0±5.72 (91.9–100.0) |
Values are presented as number or mean±standard deviation (range).
ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.
Mean operating times and blood loss
| Fusion method | Operating time (min) | Blood loss (mL) |
|---|---|---|
| ALIF (n=6) | 198.4±81.5 | 278.5±144.4 |
| PLIF (n=7) | 173.3±64.3 | 440.2±198.8 |
| TLIF (n=2) | 173.2±40.0 | 467±25.5 |
Values are presented as mean±standard deviation.
ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.
Visual Analog Scale values
| Fusion method | Preoperative | Postoperative | Difference |
|---|---|---|---|
| ALIF | 7.4±0.6 | 2.5±0.74 | 5.0±0.86 |
| PLIF | 7.6±0.38 | 2.4±0.71 | 5.5±0.71 |
| TLIF | 6.5±0.81 | 2.1±0.53 | 4.3±0.26 |
Values are presented as mean±standard deviation.
ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.
Oswestry Disability Index values
| Fusion method | Preoperative | Postoperative | Difference |
|---|---|---|---|
| ALIF | 54.8±4.28 | 21.2±5.8 | 32.0±8.48 |
| PLIF | 52.2±17.62 | 15.3±7.71 | 31.1±14.66 |
| TLIF | 53.8±5.31 | 14.6±3.18 | 39.2±2.21 |
Values are presented as mean±standard deviation.
ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.
Japanese Orthopaedic Association value
| Fusion method | Preoperative | Postoperative | Difference |
|---|---|---|---|
| ALIF | 12.4±2.52 | 20.87±4.86 | 8.51±2.67 |
| PLIF | 9.3±1.5 | 13.6±0.8 | 4.3 |
Values are presented as mean±standard deviation.
ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion.
Intra and postoperative complications for each approach
| Complications | ALIF | PLIF | TLIF |
|---|---|---|---|
| Vascular injury | 24 | 0 | 0 |
| Dural leakage | 0 | 37 | 5 |
| Peritoneal opening | 12 | 0 | 0 |
| Wound infection | 18 | 16 | 2 |
| Non-union | 5 | 18 | 10 |
| Implant failure | 15 | 33 | 11 |
| Cage migration | 0 | 10 | 10 |
| Neurological deficits | 12 | 73 | 38 |
| Adjacent segment disease | 11 | 31 | 0 |
| Ileus | 17 | 0 | 4 |
| Deep vein thrombosis/pulmonary embolism | 5 | 2 | 0 |
| Retrograde ejaculation | 16 | 0 | 0 |
| Incisional hernia | 5 | 0 | 0 |
| Pneumonia | 2 | 1 | 4 |
| Hematoma | 4 | 6 | 0 |
| Stroke | 0 | 1 | 0 |
ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion; TLIF, transforaminal lumbar interbody fusion.